ACCESS oncology and Zentaris sign product partnership.
D017322:Clinical Trials, Phase II as Topic; D003299:Cooperative Behavior; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use
D010767:Phosphorylcholine; C105905:perifosine